![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Company type
Develops fully human therapeutic monoclonal antibody (mAb)Funding rounds
Series A
( )
| Investor | Profile | Country | |
|---|---|---|---|
|
Novartis Venture Funds | The corporate venturing arm of Novartis. |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
| Investor | Profile | Country | |
|---|---|---|---|
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
Investment activity status
Active investor